Prognostic factors in uterine sarcoma

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 25, Issue 6, 2011, Pages 783-795

  Gadducci, Angiolo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

adenosarcoma; carcinosarcoma; endometrial stromal sarcoma; leiomyosarcoma; undifferentiated stromal sarcoma; uterine sarcoma

Indexed keywords

TUMOR MARKER;

ADENOSARCOMA; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CARCINOSARCOMA; DISEASE FREE SURVIVAL; ENDOMETRIUM SARCOMA; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; UTERUS SARCOMA;

EID: 80055041432     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.06.002     Document Type: Review

References (100)

1. O.M. Salazar, and M.E. Dunne The role of radiation therapy in the management of uterine sarcomas Int J Radiat Oncol Biol Phys 6 1980 899 902 (Pubitemid 10015046)
2. A. Berchuck, S.C. Rubin, and W.J. Hoskins Treatment of uterine leiomyosarcoma Obstet Gynecol 71 1988 845 850
3. F.J. Major, J.A. Blessing, and S.G. Silverberg Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 4 Suppl. 1993 1702 1709 (Pubitemid 23056094)
4. A. Gadducci, F. Landoni, and E. Sartori Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 1996 25 32 (Pubitemid 26234541)
5. A. Gadducci, E. Sartori, and F. Landoni Endometrial stromal sarcoma: analysis of treatment failures and survival Gynecol Oncol 63 1996 247 253 (Pubitemid 26398607)
6. E. Sartori, L. Bazzurini, and A. Gadducci Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study Gynecol Oncol 67 1997 70 75 (Pubitemid 27433331)
7. A. Gadducci, E. Sartori, and F. Landoni The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases Eur J Gynaecol Oncol 23 2002 295 299 (Pubitemid 34948043)
8. P. Pautier, C. Genestie, and A. Rey Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 2000 1425 1431 (Pubitemid 30155181)
9. R.L. Giuntoli 2nd, and R.E. Bristow Uterine leiomyosarcoma: present management Curr Opin Oncol 16 2004 324 327 (Pubitemid 38870037)
10. K.L. Kelly, and P.S. Craighead Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre Int J Gynecol Cancer 15 2005 132 139 (Pubitemid 40194344)
11. A. Gadducci, S. Cosio, and A. Romanini The management of patients with uterine sarcoma: a debated clinical challenge Crit Rev Oncol Hematol 65 2008 129 142
12. R. Koivisto-Korander, R. Butzow, and A.M. Koivisto Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001 Gynecol Oncol 111 2008 74 81
13. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 2008 820 830 (Pubitemid 351240576)
14. N.S. Reed, C. Mangioni, and H. Malmström Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 44 2008 808 818
15. F. Amant, A. Coosemans, and M. Debiec-Rychter Clinical management of uterine sarcomas Lancet Oncol 10 2009 1188 1198
16. V.M. Abeler, O. Røyne, and S. Thoresen Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients Histopathology 54 2009 355 364
17. J.H. Nam, and J.Y. Park Update on treatment of uterine sarcoma Curr Opin Obstet Gynecol 22 2010 36 42
18. E. D'Angelo, and J. Prat Uterine sarcomas: a review Gynecol Oncol 116 2010 131 139
19. World Health Organization classification of tumours F.A. Tavassoli, and P. Devilee Pathology and genetics of tumours of the breast and female genital organs 2003 IARC Press Lyon
20. J. Prat FIGO staging for uterine sarcomas Int J Gynaecol Obstet 104 2009 177 178
21. K.S. Olah, J.A. Dunn, and H. Gee Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma Br J Obstet Gynaecol 99 1992 590 594
22. N. Wilkinson, and T.P. Rollason Recent advanced in the pathology of smooth muscle tumours of the uterus Histopathology 39 2001 331 341 (Pubitemid 32990082)
23. S.W. Bell, R.L. Kempson, and M.R. Hendrickson Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases Am J Surg Pathol 18 1994 535 558 (Pubitemid 24150803)
24. A. Al-Nafussi Uterine smooth-muscle tumours: practical approach to diagnosis Curr Diagn Pathol 10 2004 140 156 (Pubitemid 38520433)
25. C. Zaloudek, and M.R. Hendrickson Mesenchymal tumors of the uterus R.J. Kurman, Blaustein's pathology of the female genital tract 2002 Springer-Verlag New York 561 615
26. R.J. Kurman, and H.J. Norris Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma. A clinical and pathological analysis of 26 cases Cancer 37 1976 1853 1865
27. K. Atkins, S. Bell, and M. Kempson Myxoid smooth muscle tumors of the uterus Mod Pathol 132A 2001 14
28. O.M. Salazar, T.A. Bonfiglio, and S.F. Patten Uterine sarcomas: natural history, treatment and prognosis Cancer 42 1978 1152 1160 (Pubitemid 9054573)
29. K.V. Kahanpaa, T. Wahlstrom, and P. Grohn Sarcomas of the uterus: a clinicopathologic study of 119 patients Obstet Gynecol 67 1986 417 424 (Pubitemid 16129989)
30. R.R. Nordal, G.B. Kristensen, and J. Kaern The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma Acta Oncol 34 1995 797 802
31. R. Blom, C. Guerrieri, and O. Stâl Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases Gynecol Oncol 68 1998 54 61 (Pubitemid 28109824)
32. K. Mayerhofer, A. Obermair, and G. Windbichler Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases Gynecol Oncol 74 1999 196 201 (Pubitemid 29377212)
33. R.L. Giuntoli 2nd, D.S. Metzinger, and C.S. DiMarco Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 89 2003 460 469 (Pubitemid 36687793)
34. K. Mayerhofer, P. Lozanov, and K. Bodner Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma Gynecol Oncol 92 2004 175 179 (Pubitemid 38147387)
35. M.M. Leitao, R.A. Soslow, and D. Nonaka Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 101 2004 1455 1462 (Pubitemid 39180402)
36. T.I. Wu, T.C. Chang, and S. Hsueh Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Gynecol Oncol 100 2006 166 172 (Pubitemid 41815068)
37. S.E. Anderson, D. Nonaka, and S. Chuai p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas Int J Gynecol Cancer 16 2006 849 853
38. A.L. Leiser, S.E. Anderson, and D. Nonaka Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma Gynecol Oncol 101 2006 86 91
39. E. D'Angelo, L.G. Spagnoli, and J. Prat Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system Hum Pathol 40 2009 1571 1585
40. M. Pelmus, F. Penault-Llorca, and L. Guillou Prognostic factors in early-stage leiomyosarcoma of the uterus Int J Gynecol Cancer 19 2009 385 390
41. B.A. Goff, L.W. Rice, and D. Fleischhacker Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence Gynecol Oncol 50 1993 105 109 (Pubitemid 23235520)
42. M.M. Leitao, Y. Sonoda, and M.F. Brennan Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol Oncol 91 2003 209 212 (Pubitemid 37188613)
43. T.A. Dinh, E.A. Oliva, and A.F. Fuller Jr. The treatment of uterine leiomyosarcoma: results from a 10-year experience (1990-1999) at the Massachusetts General Hospital Gynecol Oncol 92 2004 648 652 (Pubitemid 38183158)
44. A. Ayhan, G. Aksan, and M. Gultekin Prognosticators and the role of lymphadenectomy in uterine leiomyosarcomas Arch Gynecol Obstet 280 2009 79 85
45. Y. Fong, D.G. Coit, and J.M. Woodruff Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients Ann Surg 217 1993 72 77
46. K.A. Behranwala, R. A'Hern, and A.M. Omar Prognosis of lymph node metastasis in soft tissue sarcoma Ann Surg Oncol 11 2004 714 719 (Pubitemid 40486707)
47. M. Emoto, H. Iwasaki, and M. Ishiguro Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements Hum Pathol 30 1999 1232 1241 (Pubitemid 29480894)
48. S. Arita, F. Kikkawa, and H. Kajiyama Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma Int J Gynecol Cancer 15 2005 329 336 (Pubitemid 40396974)
49. S.E. Akhan, E. Yavuz, and A. Tecer The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study Gynecol Oncol 99 2005 36 42 (Pubitemid 41354580)
50. Y.L. Zhai, Y. Kobayashi, and A. Mori Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas Int J Gynecol Pathol 18 1999 20 28 (Pubitemid 29028841)
51. K. Mittal, and R.I. Demopoulos MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors Hum Pathol 32 2001 984 987 (Pubitemid 32911322)
52. K. Bodner, B. Bodner-Adler, and O. Kimberger Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters Anticancer Res 23 2003 729 732 (Pubitemid 36358480)
53. Y. Kitaoka, J. Kitawaki, and H. Koshiba Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters J Steroid Biochem Mol Biol 88 2004 183 189 (Pubitemid 38482035)
54. K. Watanabe, and T. Suzuki Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics Histopathology 48 2006 563 568
55. W.A. Peters Jr., D.R. Howard, and W.A. Andersen Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential Am J Obstet Gynecol 166 1992 1646 1653
56. S. Amada, H. Nakano, and M. Tsuneyoshi Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins Int J Gynecol Pathol 14 1995 134 142
57. K. Mayerhofer, P. Lozanov, and K. Bodner Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS) Acta Obstet Gynecol Scand 83 2004 1085 1088 (Pubitemid 39457489)
58. C.J. O'Neill, H.A. McBride, and L.E. Connolly Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential Histopathology 50 2007 851 858 (Pubitemid 46850073)
59. L. Chen, and B. Yang Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors Int J Gynecol Pathol 27 2008 326 332
60. P.E. O'Reilly, S.S. Raab, and T.H. Nieman p53, proliferating cell nuclear antigen, and KI-67 expression in extrauterine leiomyosarcomas Mod Pathol 10 1997 91 97 (Pubitemid 27110032)
61. Y.L. Zhai, T. Nikaido, and T. Shiozawa Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus Int J Cancer 84 1999 244 250 (Pubitemid 29256749)
62. K.A. Atkins, N. Arronte, and C.J. Darus The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors Am J Surg Pathol 32 2008 98 102
63. B. Bodner-Adler, K. Bodner, and K. Czerwenka Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis Gynecol Oncol 96 2005 62 66 (Pubitemid 39612418)
64. R. Maestro, A.P. Dei Tos, and Y. Hamamori Twist is a potential oncogene that inhibits apoptosis Genes 13 1999 2207 2217 (Pubitemid 29426726)
65. A. Berchuck, S.C. Rubin, and W.J. Hoskins Treatment of endometrial stromal tumors Gynecol Oncol 36 1990 60 65 (Pubitemid 20038003)
66. K.L. Chang, G.S. Crabtree, and S.K. Lim-Tan Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases Am J Surg Pathol 14 1990 415 438 (Pubitemid 20140662)
67. O. Reich, S. Regauer, and W. Urdl Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas Br J Cancer 82 2000 1030 1034 (Pubitemid 30128855)
68. M.C. Chu, G. Mor, and C. Lim Low-grade endometrial stromal sarcoma: hormonal aspects Gynecol Oncol 90 2003 170 176 (Pubitemid 37338093)
69. P.E. Schwartz, M.C. Chu, and W. Zheng Endometrial stromal tumors-are they hormonally sensitive? A.R. Genazzani, Hormone replacement therapy and cancer. The current status of research and practice 2002 The Parthenon Publishing Group Boca Raton, London, New York, Washington DC 148 154
70. D. Pink, T. Lindner, and A. Mrozek Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature Gynecol Oncol 101 2006 464 469 (Pubitemid 44251067)
71. R.R. Nordal, G.B. Kristensen, and J. Kaern The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma Gynecol Oncol 62 1996 254 259 (Pubitemid 26274808)
72. I. Chew, and E. Oliva Endometrial stromal sarcomas: a review of potential prognostic factors Adv Anat Pathol 17 2010 113 121
73. K. Bodner, B. Bodner-Adler, and A. Obermair Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients Gynecol Oncol 81 2001 160 165 (Pubitemid 32424154)
74. J.K. Chan, N.M. Kawar, and J.Y. Shin Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 2008 1210 1215
75. G. Garg, J.P. Shah, and E.P. Toy Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 118 2010 8 13
76. H.L. Evans Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma Cancer 50 1982 2170 2182 (Pubitemid 13203626)
77. O. Reich, R. Winter, and S. Regauer Should lymphadenectomy be performed in patients with endometrial stromal sarcoma Gynecol Oncol 97 2005 982 983 (Pubitemid 40824683)
78. J. Riopel, M. Plante, and M.C. Renaud Lymph node metastases in low-grade endometrial stromal sarcoma Gynecol Oncol 96 2005 402 426
79. N. Li, L.Y. Wu, and H.T. Zhang Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases Gynecol Oncol 108 2008 306 311 (Pubitemid 351174299)
80. A.J. Li, R.L. Giuntoli 2nd, and R. Drake Ovarian preservation in stage I low-grade endometrial stromal sarcomas Obstet Gynecol 106 2005 1304 1308 (Pubitemid 41668950)
81. F. Amant, A. De Knijf, and B. Van Calster Clinical study investigating the role of lymphadenectomy, surgical castration, and adjuvant hormonal treatment in endometrial stromal sarcoma Br J Cancer 97 2007 1194 1199 (Pubitemid 350035798)
82. P.A. De Fusco, T.A. Gaffey, and G.D. Malkasian Jr. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980 Gynecol Oncol 35 1989 8 14 (Pubitemid 19257737)
83. S. Kurihara, Y. Oda, and Y. Ohishi Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases Am J Surg Pathol 32 2008 1228 1238
84. P.B. Clement Mullerian adenosarcomas of the uterus with sarcomatous overgrowth: a clinicopathological analysis of 10 cases Am J Surg Pathol 13 1989 28 38 (Pubitemid 19015527)
85. P.B. Clement, and R.E. Scully Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature Hum Pathol 21 1990 363 381 (Pubitemid 20141021)
86. T. Kaku, S.G. Silverberg, and F.J. Major Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases Int J Gynecol Pathol 11 1992 75 78
87. J.D. Seidman, C.S. Wasserman, and L.M. Aye Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth Am J Surg Pathol 23 1999 809 814 (Pubitemid 29307687)
88. T.C. Krivak, J.D. Seidman, and J.W. McBroom Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival Gynecol Oncol 83 2001 89 94 (Pubitemid 32959883)
89. W.A. Peters 3rd, N.B. Kumar, and W.P. Fleming Prognostic features of sarcomas and mixed tumors of the endometrium Obstet Gynecol 63 1984 550 556 (Pubitemid 14175024)
90. M.A. Macasaet, M. Waxman, and R.G. Fruchter Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus Gynecol Oncol 2 1985 32 42 (Pubitemid 15152863)
91. T.V. Dinh, R.E. Slavin, and B.S. Bhagavan Mixed Müllerian tumors of the uterus: a clinicopathologic study Obstet Gynecol 74 1989 388 392 (Pubitemid 19213929)
92. S.N. Nielsen, K.C. Podratz, and B.W. Scheithauer Clinicopathologic analysis of uterine malignant mixed mullerian tumors Gynecol Oncol 34 1989 372 378 (Pubitemid 19218581)
93. C. Marth, G. Windbichler, and E. Petru Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium Gynecol Oncol 64 1997 121 125 (Pubitemid 27026968)
94. R. Blom, C. Guerrieri, and O. Stâl Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and. Malignant mixed mdm-2 analysis of 44 cases Gynecol Oncol 68 1998 18 24 (Pubitemid 28109817)
95. Y. Iwasa, H. Haga, and I. Konishi Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients Cancer 82 1998 512 519 (Pubitemid 28112990)
96. S.D. Yamada, R.A. Burger, and W.R. Brewster Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus Cancer 88 2000 2782 2786 (Pubitemid 30417939)
97. S.M. Temkin, M. Hellmann, and Y.C. Lee Early-stage carcinosarcoma of the uterus: the significance of lymph node count Int J Gynecol Cancer 17 2007 215 219 (Pubitemid 46213993)
98. J. Gonzalez Bosquet, and S.A. Terstriep The impact of multi-modal therapy on survival for uterine carcinosarcomas Gynecol Oncol 116 2010 419 423
99. S.E. Ferguson, C. Tornos, and A. Hummer Prognostic features of surgical stage I uterine carcinosarcoma Am J Surg Pathol 31 2007 1653 1661 (Pubitemid 350287563)
100. G.S. Huang, L.G. Chiu, and J.S. Gebb Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma Gynecol Oncol 107 2007 513 517 (Pubitemid 350160866)